Ireland
--:--IST
Starting soon Not applicable

Benefits of Early Proprioceptive Re-education Without Visual Information After Total Knee Arthroplasty

NCT06936267 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-03
Last updated
2026-02-18

Condition(s) studied

Unilateral Primary Osteoarthritis, Left Knee

Investigational drug(s) / intervention(s)

rehabilitation : eyes closedrehabilitation : eyes open

rehabilitation : eyes closed: proprioceptive exercise with eyes closed

rehabilitation : eyes open: proprioceptive exercise with eyes open

Study summary

Osteoarthritis is a common and disabling joint disease, affecting 4.7% of men and 6.6% of women in France. It causes pain and impaired joint mobility, as well as a reduction in proprioception due to damage to intra-articular mechanoreceptors. In the long term, gonarthrosis can lead to limitations in activities of daily living and increase the risk of falls and institutionalisation.

Total knee arthroplasty is an effective treatment for reducing pain and improving functional capacity. However, 50% of patients operated on are not satisfied with the results obtained at 6 months, and between 37% and 55% experience no significant improvement in their functional mobility. It is therefore important to better define the modalities of rehabilitation interventions in order to improve their efficiency and the functional benefits for the patient.

Proprioception, the visual system and the vestibular system are the three major systems involved in posture and balance. Rehabilitation interventions aimed at improving balance involve these three inputs and their interaction. Studies have shown that proprioceptive rehabilitation can significantly improve balance and gait in patients who have undergone total knee arthroplasty. However, visual feedback may hinder the development of balance skills by limiting the use of other sensorimotor systems.

Eligibility

Sex
ALL
Min age
60 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Patient aged between 60 and 85 having undergone primary total knee arthroplasty for gonarthrosis * Patient admitted to a Continuing Care and Rehabilitation (CCR) department and having received a maximum of 1 functional re-education session * Patient able to remain in bipodal support with eyes closed for 30 seconds on inclusion * Weight below the limit accepted by the posturography platform (100 kg) * Patient having read and understood the information letter and having signed the consent form * Affiliation with the social security system Exclusion Criteria: * Blindness * Diabetes with peripheral neuropathy * Central or peripheral nerve pathology (cerebellar syndrome, stroke sequelae, etc.) * Previously known ataxia * Alcoholism not withdrawn * Pre-existing gait disorders making assessment impossible * Disorders of the vestibular system * Inflammatory rheumatism * Length of stay in surgery \> 7 days * Person deprived of liberty by administrative or judicial decision or person placed under court protection / sub-guardianship or guardianship

Primary outcome measure(s)

  • the length of the projection of the centre of gravity on a posturography platform, in bipedal support, eyes closed, over 30 seconds — 3 weeks after randomization
    The main evaluation criterion is the length of the trace of the projection of the centre of gravity on a posturography platform, in bipedal support, eyes closed, over 30 seconds at 3 weeks (± 5 days) post-operatively or at discharge from the rehabilitation department, at the first intervening element. For this protocol, the posturographic analysis will be performed in the gait analysis laboratory of the Rouen Normandy University Hospital (Neurophysiology Department), by an investigator blinded to the treatment arm and trained in the use of the software.

Trial sites (2)

FacilityCityRegionStatus
CRMPR - les herbiers Bois-Guillaume France
Chu Rouen Rouen France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06936267 on ClinicalTrials.gov ↗ ← All trials in France